With the general aim of establishing a European Platform for systematic collection, exchange and analysis of longitudinal data on Multiple Sclerosis (MS) in Europe, the EUReMS project is set up by an international consortium to address the currently unmet needs of People with Multiple Sclerosis (PwMS)that have been identified by the Consortium as:
-lack of knowledge on the causes of MS;
-scarce knowledge on effectiveness of MS disease modifying drugs;
-lack of data on the burden of MS in Europe.
EUReMS is underpinned by the following principles:
-it should be built on already existing national or regional data collections;
-it should involve and combine the expertise of clinicians, researchers and patient organizations;
-it should address questions at an international level;
-it should include highest available expertise concerning its organization and technical solutions;
-it should ultimately contribute to improve access for PwMS across Europe to evidence-based health care services and offer a cutting-edge research tool to gain further insight into various aspects of MS.


The Triple S-AGE project aims to review and analyse European Syndromic Surveillance activities across Member States (MS) in order to define a generic European surveillance strategy which will help MS to implement Syndromic Surveillance with a minimal EU common approach, according to data and systems available at national level.

Its specific objectives are:
1. To provide MS, ECDC and relevant bodies with an overview of the available systems of SyS in Europe.
2. Support harmonization of main data sources for morbidity systems.
3. Support the development and implementation of SyS systems at MS level according to MS needs and expectations.
4. Develop synergies between SyS (animal and human SyS) and promote dialogue and complementarities between SyS systems, sentinel networks and specific disease surveillance networks.



The Joint Action (JA) aims to link and consolidate the objectives of two existing networks dealing with highly infectious bacteria and viruses that emerged from the EU funded project EQADeBa, coordinated by the Robert Koch-Institut (RKI), Germany (EAHC no 2007 204) and the ENP4-Lab project, coordinated by L.Spallanzani National Institute for Infectious Diseases (INMI), Italy (EAHC no 2006 208). The primary objective of the current application is to stabilise both network activities that link 33 partners from 21 European countries highly specialised and advanced laboratories. This will ensure the universal exchange of best diagnostic strategies able to support a European response strategy to outbreaks of highly pathogenic infectious agents plus generating a biodiverse repository of reference materials. The JA will provide a supportive European infrastructure and strategy for external quality assurance exercises (EQAE, bacterial antibiotic susceptibility testing, training, and biosafety and biosecurity review of current practices).


The general objectives are to improve the knowledge and the procedures for psychological support in hospitals during the acute phase of a catastrophe, when a high number of people arrive at the hospital in a very short time. In those circumstances the focus is on health and logistics and the major concerns are the physical injuries of persons and the destruction of the environment.


• Strengthen legal tools in support of disease preparedness and control.
• Support the development of coherent European legal responses to the human pandemic influenza threat.
• Develop and support a network of expertise, knowledge and shared experience in public health law in relation to disease preparedness and control across the European Union.
